KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

BioNTech SE (BNTX) Operating Margin (2018 - 2025)

BioNTech SE's Operating Margin history spans 8 years, with the latest figure at 870.08% for Q4 2025.

  • On a quarterly basis, Operating Margin fell 87009.0% to 870.08% in Q4 2025 year-over-year; TTM through Dec 2025 was 84.21%, a 8417.0% decrease, with the full-year FY2025 number at 48.95%, up 119095.0% from a year prior.
  • Operating Margin hit 870.08% in Q4 2025 for BioNTech SE, down from 3.09% in the prior quarter.
  • Over the last five years, Operating Margin for BNTX hit a ceiling of 84.95% in Q4 2021 and a floor of 6424.36% in Q2 2025.
  • Historically, Operating Margin has averaged 511.6% across 5 years, with a median of 26.44% in 2023.
  • Biggest five-year swings in Operating Margin: skyrocketed 1425bps in 2021 and later crashed -567362bps in 2025.
  • Tracing BNTX's Operating Margin over 5 years: stood at 84.95% in 2021, then fell by -9bps to 76.97% in 2022, then crashed by -54bps to 35.58% in 2023, then plummeted by -100bps to 0.0% in 2024, then plummeted by -19322219bps to 870.08% in 2025.
  • Business Quant data shows Operating Margin for BNTX at 870.08% in Q4 2025, 3.09% in Q3 2025, and 6424.36% in Q2 2025.